News for Healthier Living

HSS Studies Identify Potential Profile and Treatment Options for Mild Traumatic Brain Injury

Two studies by scientists at Hospital for Special Surgery (HSS) offer possible insights into treating mild traumatic brain injury (mTBI), including a potential blood biomarker for injury assessment that could shed light on the role of inflammation, and evidence supporting the use of amitriptyline, historically used as an anti-depressant, but now commonly used for migraine relief, to speed recovery. The research team shared their results today at the American Academy of Neurology 2025 annual meeting.

April 8, 2025


April 12 2025

April 11 2025

April 10 2025

April 9 2025

April 8 2025

April 7 2025

April 5 2025

April 4 2025

April 3 2025

April 2 2025

April 1 2025

March 31 2025

March 30 2025

March 29 2025